Activation of the mTOR/HIF‐1α/VEGF axis promotes M1 macrophage polarization in non‐eosinophilic chronic rhinosinusitis with nasal polyps
Activation of the mTOR/HIF‐1α/VEGF axis promotes M1 macrophage polarization in non‐eosinophilic chronic rhinosinusitis with nasal polyps
复制标题
DOI:
10.1111/all.15050
复制
发表时间:
2021-08
期刊:
影响因子:
12.4
通讯作者:
B. Zhong;Jin-Tao Du;Feng Liu;Ya-Feng Liu;Shixi Liu;Lifeng Xie;Deyun Wang;L. Ba
中科院分区:
文献类型:
--
作者:
B. Zhong;Jin-Tao Du;Feng Liu;Ya-Feng Liu;Shixi Liu;Lifeng Xie;Deyun Wang;L. Ba
To the Editor, Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the sinonasal mucosa. Eosinophilic CRSwNP (eosCRSwNP) is characterized by predominant tissue eosinophilic infiltration as compared to relatively low eosinophilic infiltration (noneosCRSwNP) of the nasal polyps. At present, most studies have focused on the mechanisms underlying eosCRSwNP; however, noneosCRSwNP is largely unexplored. Hypoxiainduced factor1α (HIF1α) is a stable factor under hypoxic conditions that has been shown to play an important role in respiratory diseases. HIF1α has been shown to be highly expressed in M1 macrophages in noneosCRSwNP and to be involved in the Th1 inflammatory response.1 Mammalian target of rapamycin (mTOR) is a serine/threonine kinase with signaling pathway regulates many aspects of cell physiology, such as proliferation, autophagy, and apoptosis, which have been previously reported to be involved in the regulation of HIF1α.2 However, the relationship between mTOR and HIF1α in CRSwNP and its pathological mechanism remains unclear. In addition, the effect of regulatory mechanism on expression of vascular endothelial growth factor (VEGF), an important downstream factor of HIF1α, is also worthy of further investigation. Here, we sought to determine the role of mTOR, HIF1α, and VEGF in noneosCRSwNP inflammation. First, immunohistochemistry, Western blotting, and qPCR revealed that the levels of INOS, CD86, pmTOR, and HIF1α in noneosCRSwNP tissue samples were higher than those in control and eosCRSwNP samples (Figure 1A). Vascular endothelial growth factor (VEGF) in CRSwNP was higher than the control group. Moreover, a correlation analysis indicated that the levels of INOS and CD86 were positively correlated with those of mTOR, HIF1α, and VEGF, including immunohistochemistry and qPCR, although the immunohistochemical level of pmTOR was not strongly correlated with HIF1α and VEGF (Figure S1). Next, we found that pmTOR, HIF1α, and VEGF were costained with CD86, a marker specific for M1 macrophages in noneosCRSwNP (Figure 2). We confirmed the specificity of M1 macrophages by costaining CD86 with iNOS, another marker of M1 macrophages (Figure S2). Then, we differentiated THP1 cells into macrophages and stimulated them with IFNγ and LPS (Figure S3A), which resulted in increased expression of CD86 and iNOS (Figure S3B), and mRNA levels of TNFα and IL12 (Figure S3C). These results suggested M1 macrophage polarization in noneosCRSwNP samples. Importantly, subsequent immunofluorescence results showed that the degree of CD86 and pmTOR costaining in macrophages stimulated with IFNγ and LPS was significantly higher than that in the control group. We next treated macrophages either with the mTOR inhibitor rapamycin (RAPA) or the HIF1α inhibitor KC7F2 (KC) or the VEGF inhibitor V1Calbiochem (V1) prior to stimulation to confirm the relationship between mTOR, HIF1α, and VEGF and macrophage polarization. The levels of costained CD86/pmTOR, CD86/HIF1α, and CD86/VEGF were higher in the macrophages stimulated by IFNγ and LPS than in the control group. RAPA treatment significantly reduced the levels of costained CD86/pmTOR (Figure S4A). Although KC treatment also had a reducing effect, it was not as pronounced as that of RAPA treatment. In addition, V1 could inhibit the expression of CD86, but had no significant effect on pmTOR and HIF1α. Moreover, both RAPA and KC reduced the levels of costained CD86/HIF1α and CD86/VEGF (Figure S4B), while V1 can only inhibit the expression of CD86/VEGF (Figure S5A). In addition, we also detected the expression of INOS, which was similar to that of CD86 (Figure S5B). Furthermore, Western blot and qPCR results showed a similar trend (Figure S6). Previous studies have shown that mTOR can directly regulate the expression of HIF1α and further regulate neutrophil extracellular trap formation,3 which may explain the increased expression of mTOR and HIF1α in noneosCRSwNP characterized by neutrophil infiltration. Indeed, mTOR upregulates VEGF expression through HIF1α,4 which is consistent with our findings. Some reports have demonstrated that LPS and IFNγ increase HIF1α expression in the process of M1 macrophage polarization.5 Similarly, increased levels of HIF1α also promote the proliferation of M1 macrophages.1 Interestingly, the abnormal activation of mTORC1 can also directly promote M1 polarization.6 In our study, inhibition of mTOR, HIF1α, and VEGF all reduced the polarization of M1 macrophages, but inhibition of mTOR could downregulate the expression of HIF1α and VEGF. While inhibition of both HIF1α and VEGF showed no significant effect on the expression of mTOR. In addition, inhibition of HIF1α decreased VEGF levels. Therefore, mTOR may promote M1 macrophage polarization and lead to inflammation by stimulating HIF1α and VEGF expression in noneosCRSwNP.